Table of Contents Author Guidelines Submit a Manuscript
Pulmonary Medicine
Volume 2011, Article ID 858154, 8 pages
http://dx.doi.org/10.1155/2011/858154
Clinical Study

Patient Characteristics in Persistent Pulmonary Hypertension of the Newborn

1Department of Paediatric Cardiology, Beatrix Children's Hospital, University Medical Centre Groningen, University of Groningen, Hanzeplein 1, 9700 RB Groningen, The Netherlands
2Department of Neonatology, Beatrix Children's Hospital, University Medical Centre Groningen, University of Groningen, Hanzeplein 1, 9700 RB Groningen, The Netherlands

Received 14 December 2010; Revised 25 March 2011; Accepted 28 March 2011

Academic Editor: Irwin Reiss

Copyright © 2011 M. T. R. Roofthooft et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. T. R. Roofthooft, K. A. Bergman, T. W. Waterbolk, T. Ebels, B. Bartelds, and R. M. F. Berger, “Persistent pulmonary hypertension of the newborn with transposition of the great arteries,” Annals of Thoracic Surgery, vol. 83, no. 4, pp. 1446–1450, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. P. S. Shah and A. Ohlsson, “Sildenafil for pulmonary hypertension in neonates,” Cochrane Database of Systematic Reviews, no. 3, Article ID CD005494, 2007. View at Google Scholar
  3. M. Ellington Jr., D. O'Reilly, E. N. Allred, M. C. McCormick, D. L. Wessel, and S. Kourembanas, “Child health status, neurodevelopmental outcome, and parental satisfaction in a randomized, controlled trial of nitric oxide for persistent pulmonary hypertension of the newborn,” Pediatrics, vol. 107, no. 6, pp. 1351–1356, 2001. View at Publisher · View at Google Scholar
  4. H. Ichiba, S. Matsunami, F. Itoh, T. Ueda, Y. Ohsasa, and T. Yamano, “Three-year follow up of term and near-term infants treated with inhaled nitric oxide,” Pediatrics International, vol. 45, no. 3, pp. 290–293, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. A. M. Leavitt, J. F. Watchko, F. C. Bennett, and R. C. Folsom, “Neurodevelopmental outcome following persistent pulmonary hypertension of the neonate,” Journal of Perinatology, vol. 7, no. 4, pp. 288–291, 1987. View at Google Scholar · View at Scopus
  6. P. H. Lipkin, D. Davidson, L. Spivak, R. Straube, J. Rhines, and C. T. Chang, “Neurodevelopmental and medical outcomes of persistent pulmonary hypertension in term newborns treated with nitric oxide,” Journal of Pediatrics, vol. 140, no. 3, pp. 306–310, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. J. C. Bernbaum, P. Russell, and P. H. Sheridan, “Long-term follow-up of newborns with persistent pulmonary hypertension,” Critical Care Medicine, vol. 12, no. 7, pp. 579–583, 1984. View at Google Scholar · View at Scopus
  8. F. C. Verhulst, J. van der Ende, and H. M. Koot, “Manual for the Child Behaviour Checklist/4-18,” Dutch Department of Child Psychiatrie, Sophia Childrens Hospital Rotterdam, 1996.
  9. V. H. Kumar, A. A. Hutchison, S. Lakshminrusimha, F. C. Morin, R. J. Wynn, and R. M. Ryan, “Characteristics of pulmonary hypertension in preterm neonates,” Journal of Perinatology, vol. 27, no. 4, pp. 214–219, 2007. View at Publisher · View at Google Scholar · View at PubMed
  10. S. Dakshinamurti, “Pathophysiologic mechanisms of persistent pulmonary hypertension of the newborn,” Pediatric Pulmonology, vol. 39, no. 6, pp. 492–503, 2005. View at Publisher · View at Google Scholar · View at PubMed
  11. S. E. Andrade, H. McPhillips, D. Loren et al., “Antidepressant medication use and risk of persistent pulmonary hypertension of the newborn,” Pharmacoepidemiology and Drug Safety, vol. 18, no. 3, pp. 246–252, 2009. View at Publisher · View at Google Scholar · View at PubMed
  12. K. L. Wilson, C. M. Zelig, J. P. Harvey, B. S. Cunningham, B. M. Dolinsky, and P. G. Napolitano, “Persistent pulmonary hypertension of the newborn is associated with mode of delivery and not with maternal use of selective serotonin reuptake inhibitors,” American Journal of Perinatology, vol. 28, no. 1, pp. 19–24, 2011. View at Publisher · View at Google Scholar · View at PubMed
  13. R. A. Ballard and C. H. Leonard, “Developmental follow-up of infants with persistent pulmonary hypertension of the newborn,” Clinics in Perinatology, vol. 11, no. 3, pp. 737–744, 1984. View at Google Scholar
  14. G. G. Konduri, B. Vohr, C. Robertson et al., “Early inhaled nitric oxide therapy for term and near-term newborn infants with hypoxic respiratory failure: neurodevelopmental follow-up,” Journal of Pediatrics, vol. 150, no. 3, pp. 235–240, 2007. View at Publisher · View at Google Scholar · View at PubMed
  15. K. D. Hendricks-Munoz and J. P. Walton, “Hearing loss in infants with persistent fetal circulation,” Pediatrics, vol. 81, no. 5, pp. 650–656, 1988. View at Google Scholar
  16. M. J. Marron, M. A. Crisafi, J. M. Driscoll et al., “Hearing and neurodevelopmental outcome in survivors of persistent pulmonary hypertension of the newborn,” Pediatrics, vol. 90, no. 3 I, pp. 392–396, 1992. View at Google Scholar
  17. E. J. Sell, J. A. Gaines, C. Gluckman, and E. Williams, “Persistent fetal circulation. Neurodevelopmental outcome,” American Journal of Diseases of Children, vol. 139, no. 1, pp. 25–28, 1985. View at Google Scholar